Skip to content
The Longevity Archive
Trontinemab in all countries

Legal status · Canada

Is Trontinemab legal in Canada?

InvestigationalNootropic & CNSEvidence: Moderate

No. Trontinemab is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Trontinemab in Canada at a glance

ClassificationInvestigational, not approved
Health Canada approval statusNot approved by Health Canada; investigational
Evidence levelModerate (research strength: Strong)
ReviewedSep 2026

Classification and note come from the Trontinemab profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.

What this means

  • 01

    Trontinemab is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What Trontinemab is

Roche's anti-amyloid antibody with a transferrin-receptor 'shuttle' that cleared amyloid in 91% of patients within seven months at a fraction of the ARIA seen with lecanemab or donanemab; Phase 3 started in 2025.

Trontinemab fuses gantenerumab to a module that binds the transferrin receptor, ferrying the antibody across the blood-brain barrier at far lower doses. 6 mg/kg produced amyloid-PET negativity in 91% of participants at 28 weeks with ARIA-E under 5%.

Mechanism: Anti-amyloid-beta antibody engineered for receptor-mediated transport across the blood-brain barrier, enabling rapid plaque removal at low systemic doses.

Regulatory history: Investigational; Phase 3

How Health Canada treats this kind of product

Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.

The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Trontinemab at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Trontinemab in other countries

Frequently asked questions

Is Trontinemab legal in Canada?

No. Trontinemab is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Can I buy Trontinemab in Canada?

No approved product exists to buy. In Canada Trontinemab is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Trontinemab Health Canada approved?

No. In Canada Trontinemab is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Investigational; Phase 3. Evidence level: Moderate.

Related compounds in Canada

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Trontinemab live on its compound profile.

Trontinemab profile

This page is general information about the regulatory status of Trontinemab in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.